{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T12:29:45Z","timestamp":1751891385988,"version":"3.33.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,18]]},"DOI":"10.7759\/cureus.77610","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T10:17:26Z","timestamp":1737195446000},"source":"Crossref","is-referenced-by-count":2,"title":["Evaluating the Safety and Efficacy of Ticagrelor vs. Clopidogrel Following Percutaneous Coronary Intervention in Chronic Coronary Disease"],"prefix":"10.7759","author":[{"given":"Muhammad Abdur","family":"Rauf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ziyad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nida","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafi","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farooq","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikram","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Muzammil","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5551\/jat.57265","article-title":"Efficacy and safety of ticagrelor and clopidogrel in patients with stable coronary artery disease undergoing percutaneous coronary intervention","volume":"28","author":"Li J","year":"2021","unstructured":"Li J, Qiu H, Yan L, et al.. Efficacy and safety of ticagrelor and clopidogrel in patients with stable coronary artery disease undergoing percutaneous coronary intervention. J Atheroscler Thromb. 2021, 28:873-82. 10.5551\/jat.57265","journal-title":"J Atheroscler Thromb"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5812\/intjcardiovascpract-150332","article-title":"Comparative analysis of ticagrelor and clopidogrel effects on medication adherence, adverse events, and laboratory parameters in Iranian acute coronary syndrome patients post-PCI","volume":"9","author":"Hamrahi V","year":"2024","unstructured":"Hamrahi V, Pishgahi M, Javan A, et al.. Comparative analysis of ticagrelor and clopidogrel effects on medication adherence, adverse events, and laboratory parameters in Iranian acute coronary syndrome patients post-PCI. Int J Cardiovasc Pract. 2024, 9:e150332. 10.5812\/intjcardiovascpract-150332","journal-title":"Int J Cardiovasc Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-22-00654","article-title":"Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes","volume":"18","author":"Koshy AN","year":"2023","unstructured":"Koshy AN, Giustino G, Sartori S, et al.. Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes. EuroIntervention. 2023, 18:1244-53. 10.4244\/EIJ-D-22-00654","journal-title":"EuroIntervention"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2024.0133","article-title":"Ticagrelor or clopidogrel monotherapy vs dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and patient-level meta-analysis","volume":"9","author":"Valgimigli M","year":"2024","unstructured":"Valgimigli M, Gragnano F, Branca M, et al.. Ticagrelor or clopidogrel monotherapy vs dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and patient-level meta-analysis. JAMA Cardiol. 2024, 9:437-48. 10.1001\/jamacardio.2024.0133","journal-title":"JAMA Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.6447","article-title":"Association of ticagrelor vs clopidogrel with major adverse coronary events in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"180","author":"Turgeon RD","year":"2020","unstructured":"Turgeon RD, Koshman SL, Youngson E, Har B, Wilton SB, James MT, Graham MM. Association of ticagrelor vs clopidogrel with major adverse coronary events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. JAMA Intern Med. 2020, 180:420-8. 10.1001\/jamainternmed.2019.6447","journal-title":"JAMA Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.61919\/jhrr.v4i2.1169","article-title":"Safety of ticagrelor in post - PCI (percutaneous coronary intervention) patients at a tertiary care hospital","volume":"4","author":"Hasan S","year":"2024","unstructured":"Hasan S, Fawad A, Mehr MT, et al.. Safety of ticagrelor in post - PCI (percutaneous coronary intervention) patients at a tertiary care hospital. J Heal Rehabil Res. 2024, 4:1565-9. 10.61919\/jhrr.v4i2.1169","journal-title":"J Heal Rehabil Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/6632656","article-title":"The comparison of the initial TIMI flow grade in acute ST-elevation myocardial infarction patients receiving ticagrelor vs. clopidogrel before undergoing primary percutaneous coronary intervention: a prospective cohort study","volume":"2024","author":"Elahifar A","year":"2024","unstructured":"Elahifar A, Rafati A, Alemzadeh-Ansari MJ, Pasebani Y, Naghshtabrizi B, Mohammadi Y, Hosseini SK. The comparison of the initial TIMI flow grade in acute ST-elevation myocardial infarction patients receiving ticagrelor vs. clopidogrel before undergoing primary percutaneous coronary intervention: a prospective cohort study. Cardiol Res Pract. 2024, 2024:6632656. 10.1155\/2024\/6632656","journal-title":"Cardiol Res Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46455","article-title":"Efficacy and safety profile of ticagrelor versus clopidogrel in percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS): a systematic review and meta-analysis","volume":"15","author":"Maqbool S","year":"2023","unstructured":"Maqbool S, Ali MS, Rehman A, et al.. Efficacy and safety profile of ticagrelor versus clopidogrel in percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS): a systematic review and meta-analysis. Cureus. 2023, 15:e46455. 10.7759\/cureus.46455","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.768190","article-title":"Ticagrelor vs. clopidogrel after complex percutaneous coronary intervention in patients with stable coronary artery disease","volume":"8","author":"Xi Z","year":"2021","unstructured":"Xi Z, Li J, Qiu H, et al.. Ticagrelor vs. clopidogrel after complex percutaneous coronary intervention in patients with stable coronary artery disease. Front Cardiovasc Med. 2021, 8:768190. 10.3389\/fcvm.2021.768190","journal-title":"Front Cardiovasc Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-019-01307-0","article-title":"Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in East Asian patients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study","volume":"20","author":"Wang Y","year":"2020","unstructured":"Wang Y, Zhao HW, Wang CF, et al.. Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in East Asian patients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study. BMC Cardiovasc Disord. 2020, 20:109. 10.1186\/s12872-019-01307-0","journal-title":"BMC Cardiovasc Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/ehaa946.1722","article-title":"Ticagrelor monotherapy vs clopidogrel monotherapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"41","author":"Feng W","year":"2020","unstructured":"Feng W, Chen PW, Ho M, et al.. Ticagrelor monotherapy vs clopidogrel monotherapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Eur Heart J. 2020, 41:ehaa946.1722. 10.1093\/ehjci\/ehaa946.1722","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-23-00427","article-title":"De-escalation from ticagrelor to clopidogrel in patients with acute myocardial infarction: the TALOS-AMI HBR substudy","volume":"19","author":"Kim MC","year":"2023","unstructured":"Kim MC, Ahn SG, Cho KH, et al.. De-escalation from ticagrelor to clopidogrel in patients with acute myocardial infarction: the TALOS-AMI HBR substudy. EuroIntervention. 2023, 19:e832-43. 10.4244\/EIJ-D-23-00427","journal-title":"EuroIntervention"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-20-00187","article-title":"A prospective, multicentre, randomised, open-label trial to compare the efficacy and safety of clopidogrel versus ticagrelor in stabilised patients with acute myocardial infarction after percutaneous coronary intervention: rationale and design of the TALOS-AMI trial","volume":"16","author":"Park MW","year":"2021","unstructured":"Park MW, Kim CJ, Kim MC, et al.. A prospective, multicentre, randomised, open-label trial to compare the efficacy and safety of clopidogrel versus ticagrelor in stabilised patients with acute myocardial infarction after percutaneous coronary intervention: rationale and design of the TALOS-AMI trial. EuroIntervention. 2021, 16:1170-6. 10.4244\/EIJ-D-20-00187","journal-title":"EuroIntervention"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32236-4","article-title":"Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial","volume":"396","author":"Silvain J","year":"2020","unstructured":"Silvain J, Lattuca B, Beygui F, et al.. Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial. Lancet. 2020, 396:1737-44. 10.1016\/S0140-6736(20)32236-4","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1713375","article-title":"Platelet inhibition with ticagrelor versus clopidogrel in diabetic patients after percutaneous coronary intervention for chronic coronary syndromes","volume":"120","author":"Liu Z","year":"2020","unstructured":"Liu Z, Tian R, Wang Y, Chen Q, Li J, Xu L, Zhang S. Platelet inhibition with ticagrelor versus clopidogrel in diabetic patients after percutaneous coronary intervention for chronic coronary syndromes. Thromb Haemost. 2020, 120:1221-9. 10.1055\/s-0040-1713375","journal-title":"Thromb Haemost"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202308_33302","article-title":"Comparison of clopidogrel vs. ticagrelor medication adherence in patients with acute coronary syndrome","volume":"27","author":"Dogan O","year":"2023","unstructured":"Dogan O, Bulat Z, Yildiz A, et al.. Comparison of clopidogrel vs. ticagrelor medication adherence in patients with acute coronary syndrome. Eur Rev Med Pharmacol Sci. 2023, 27:7309-15. 10.26355\/eurrev_202308_33302","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666200614184007","article-title":"Efficacy and safety of ticagrelor compared to clopidogrel in patients undergoing percutaneous coronary intervention: a meta-analysis","volume":"26","author":"Wu H","year":"2020","unstructured":"Wu H, Xiang X, Li D, Shen S, Li X. Efficacy and safety of ticagrelor compared to clopidogrel in patients undergoing percutaneous coronary intervention: a meta-analysis. Curr Pharm Des. 2020, 26:5988-97. 10.2174\/1381612826666200614184007","journal-title":"Curr Pharm Des"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2020.1825364","article-title":"Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease undergoing percutaneous coronary intervention","volume":"36","author":"Li J","year":"2020","unstructured":"Li J, Qiu H, Yan L, et al.. Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease undergoing percutaneous coronary intervention. Curr Med Res Opin. 2020, 36:1739-45. 10.1080\/03007995.2020.1825364","journal-title":"Curr Med Res Opin"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13665","article-title":"High-dose clopidogrel versus ticagrelor in CYP2C19 intermediate or poor metabolizers after percutaneous coronary intervention: a meta-analysis of randomized trials","volume":"47","author":"Sheng XY","year":"2022","unstructured":"Sheng XY, An HJ, He YY, Ye YF, Zhao JL, Li S. High-dose clopidogrel versus ticagrelor in CYP2C19 intermediate or poor metabolizers after percutaneous coronary intervention: a meta-analysis of randomized trials. J Clin Pharm Ther. 2022, 47:1112-21. 10.1111\/jcpt.13665","journal-title":"J Clin Pharm Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.18502\/ijph.v49i2.3086","article-title":"comparison of efficacy between clopidogrel and ticagrelor in patients with acute coronary syndrome after interventional treatment and their effects on il-6","volume":"49","author":"Yang B","year":"2020","unstructured":"Yang B, Zheng C, Yu H, et al.. comparison of efficacy between clopidogrel and ticagrelor in patients with acute coronary syndrome after interventional treatment and their effects on il-6. Iran J Public Health. 2020, 49:240-8. 10.18502\/ijph.v49i2.3086","journal-title":"Iran J Public Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/334000-evaluating-the-safety-and-efficacy-of-ticagrelor-vs-clopidogrel-following-percutaneous-coronary-intervention-in-chronic-coronary-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T10:17:28Z","timestamp":1737195448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/334000-evaluating-the-safety-and-efficacy-of-ticagrelor-vs-clopidogrel-following-percutaneous-coronary-intervention-in-chronic-coronary-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.77610","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,18]]}}}